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USP8 Promotes Smoothened Signaling by Preventing Its
Ubiquitination and Changing Its Subcellular Localization
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Department of Molecular and Cellular Biochemistry, Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America
Abstract
The seven transmembrane protein Smoothened (Smo) is a critical component of the Hedgehog (Hh) signaling pathway and
is regulated by phosphorylation, dimerization, and cell-surface accumulation upon Hh stimulation. However, it is not clear
how Hh regulates Smo accumulation on the cell surface or how Hh regulates the intracellular trafficking of Smo. In addition,
little is known about whether ubiquitination is involved in Smo regulation. In this study, we demonstrate that Smo is multi-
monoubiquitinated and that Smo ubiquitination is inhibited by Hh and by phosphorylation. Using an in vivo RNAi screen,
we identified ubiquitin-specific protease 8 (USP8) as a deubiquitinase that down-regulates Smo ubiquitination. Inactivation
of USP8 increases Smo ubiquitination and attenuates Hh-induced Smo accumulation, leading to decreased Hh signaling
activity. Moreover, overexpression of USP8 prevents Smo ubiquitination and elevates Smo accumulation, leading to
increased Hh signaling activity. Mechanistically, we show that Hh promotes the interaction of USP8 with Smo aa625–753,
which covers the three PKA and CK1 phosphorylation clusters. Finally, USP8 promotes the accumulation of Smo at the cell
surface and prevents localization to the early endosomes, presumably by deubiquitinating Smo. Our studies identify USP8
as a positive regulator in Hh signaling by down-regulating Smo ubiquitination and thereby mediating Smo intracellular
trafficking.
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Introduction
Hedgehog (Hh) proteins function as morphogens and play
critical roles in pattern formation and cell growth control. Hh
signaling has also been implicated in tissue repair and stem cell
maintenance [1]. Malfunction of Hh signaling causes birth defects
as well as several types of cancer [2,3]. The Hh signal is
transduced through a receptor complex consisting of Patched (Ptc)
and Ihog [4]. The seven transmembrane protein Smoothened
(Smo) acts as a signal transducer, and the activity of Smo is
inhibited by Ptc in the absence of Hh [5–7]. Binding of Hh to Ptc-
Ihog relieves the inhibition of Smo by Ptc, which allows Smo to
activate the cubitus interuptus (Ci)/Gli family of Zn-finger
transcription factors and thereby induce the expression of Hh
target genes, such as decapentaplegic (dpp), ptc, and en [5,7].
Posttranslational regulation of the components in the Hh signaling
pathway has been shown to be critical for their accumulation and
activation. For example, phosphorylation of Smo and Ci/Gli has
been extensively studied [8]. In Drosophila, it has been shown that
the presence of Hh promotes the hyperphosphorylation and cell
surface accumulation of Smo, whereas the absence of Hh allows
for the hyperphosphorylation and proteolytic processing of Ci [5].
Although it has been shown that ubiquitination is important for Ci
processing and degradation [9], it is not known whether
ubiquitination is involved in the posttranslational regulation of
other pathway components.
Hh induces the cell surface accumulation and phosphorylation
of Smo [10] by multiple kinases, including protein kinase A (PKA)
and casein kinase 1 (CK1) [11–13], which activate Smo by
inducing a conformational change in the protein [14]. It has been
shown that forced localization of Smo to the cell surface increases
signaling activity, whereas endoplasmic retention of an activated
form of Smo blocks activity [15]. The inhibition of endocytosis
through the use of a dominant negative form of Rab5 promotes
Smo cell surface accumulation [15]. In addition, an antibody
uptake experiment using cultured Drosophila S2 cells suggested that
Hh regulates Smo cell surface accumulation by blocking
endocytosis and/or promoting the recycling of Smo [12]. Notably,
Smo is primarily localized to the lysosomes of A-compartment cells
in Drosophila imaginal discs, where Hh is not present, and is
enriched on the plasma membrane of P-compartment cells where
Hh stimulation occurs [16]. Smo has been established as a G
protein-coupled receptor-like protein after the recent identification
of an association with Gai [17], as well as the finding that G
protein-coupled receptor kinase 2 (Gprk2) phosphorylates and
regulates Smo accumulation [18,19]. Similar mechanisms have
been proposed for the regulation of mammalian Smo, whereby
both Smo and Ptc co-localize and internalize in endosomal
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compartments, and Hh induces the segregation of Smo away from
Hh-Ptc complexes that are destined for lysosome degradation [20].
In addition, the association of Smo with b-arrestin 2 appears to
promote Smo endocytosis through clathrin-coated pits [21].
Taken together, the controlled accumulation and localization of
Smo in the Hh signaling pathway is thought to play a central role
in maintaining signaling homeostasis. However, it is yet unclear
how Hh controls the intracellular trafficking of Smo [3].
Ubiquitination is the enzymatic process by which proteins are
covalently modified with the 76 amino acid protein ubiquitin (Ub).
Ubiquitination has been shown to be important not only in the
degradation of proteins, but also in the regulation of protein
functions, such as protein activity, protein-protein interactions,
and protein trafficking [22–24]. For example, cell surface receptor
tyrosine kinases (RTKs) are monoubiquitinated at multiple sites,
which mediates the internalization and subsequent transport of the
proteins to the lysosome for destruction [25,26]. The process of
ubiquitination was shown to be a reversible modification after the
identification of a large family of de-ubiquitinating enzymes
(DUBs), which function by removing Ub conjugates from target
proteins in order to regulate their biological activity and modulate
intracellular trafficking [27]. It has recently been shown that
deubiquitinating enzyme UBPY/ubiquitin-specific protease 8
(USP8) regulates the ubiquitination of Frizzled, which is the
receptor for Wnt/Wingless [28]. In addition, deletion of UBPY/
UBP8 in mice causes embryonic lethality [29]. However, in Hh
signaling, it is currently not known whether the transmembrane
protein Smo is regulated by ubiquitination and whether
deubiquitination enzymes are involved in the sorting of Smo.
In this study, we found that Smo is monoubiquitinated, and this
process is reduced by Hh or by phosphorylation. By using an
RNAi screen that targets Drosophila DUBs in both the wings and
cultured S2 cells, we identified USP8 as a DUB that prevents Smo
ubiquitination and enhances the signaling activity of the protein.
We also show that inactivation of USP8 by RNAi or by
overexpressing a dominant negative form of USP8 increases
Smo ubiquitination in S2 cells and prevents Smo accumulation in
wing discs. The overexpression of USP8 down-regulated Smo
ubiquitination and increased Smo accumulation. In addition, we
found that USP8 is required for Hh-induced cell surface
accumulation of Smo, and that Hh promotes the interaction
between Smo and USP8 (see Figure S3). Moreover, we found that
USP8 prevents Smo localization to early endosomes that are
labeled with Rab5. Taken together, ubiquitination is likely a
negative regulatory mechanism in Smo activation and USP8 plays
an opposing role in this regulation.
Results
Smo Undergoes Monoubiquitination That Is Reduced by
Hh or Phosphorylation
In an attempt to explore whether Smo is regulated by
ubiquitination, we examined Smo ubiquitination in S2 cells using
an immunoprecipitation assay. We found that ubiquitinated Smo
was readily detected by a commercial anti-Ub (P4D1) antibody,
which detected the immunoprecipitated, endogenous Ub
(Figure 1A, lane 2, top panel). Smo ubiquitination was also
detected by an anti-hemagglutinin (HA) antibody in cells
cotransfected with an HA-tagged Ub construct (HA-Ub)
(Figure 1A, lane 4, top panel), and transfecting HA-Ub or HA-
Ub mutants coincided with the pattern of the endogenous free Ub
(Figure 1B, unpublished data). The smeared banding pattern of
ubiquitinated Smo on SDS-PAGE suggested that Smo could be
either polyubiquitinated or multi-monoubiquitinated. To differ-
entiate these possibilities, we co-transfected S2 cells with a Myc-
tagged Smo (Myc-Smo) together with various HA-Ub mutants and
performed an immunoprecipitation assay to examine the pattern
of Smo ubiquitination. As shown in Figure 1C, UbK0, a ubiquitin
variant where all of the lysine (K) residues were changed to
arginine (R), gave rise to an identically smeared banding pattern as
wild-type Ub, K48-Ub, and K63-Ub (Figure 1C, lane 9, compare
lanes 1, 7, and 8). This migration pattern was similar to the pattern
of Ub variants containing individual lysine mutations (UbKR)
(Figure 1C, lanes 3–6). These data suggest that Smo undergoes
multi-monoubiquitination.
We next wished to assess whether ubiquitination regulates Smo
function in vivo. We constructed Myc-tagged Smo that had either
a single Ub molecule or CFP cDNA fused in frame to the C-
terminus of Smo (Myc-SmoUb and Myc-SmoCFP, respectively)
and generated transgenic lines at the 75B1-VK5 attP locus to
ensure equal expression of Myc-SmoUb, Myc-SmoCFP, and Myc-
Smo [30]. Expression of Myc-Smo or Myc-SmoCFP induced an
extra structure in Vein2 and Vein3, which was indicative of
anterior ectopic Hh activity (Figure 2B and 2D). In contrast,
expression of Myc-SmoUb resulted in a wild-type wing (Figure 2C).
We further found that SmoUb preferentially localizes in the Rab7-
labeled late endosomes (Figure 2E–G), and that SmoUb was less
stable (Figure 2H) and had less responsiveness to Hh stimulation
(Figure 2I). These data suggest that ubiquitination plays a negative
role in Smo regulation.
To explore whether Hh regulates Smo ubiquitination, we
treated cells with varying concentrations of Hh-conditioned
medium and analyzed the results in the ubiquitination assay. An
increase in the concentration of Hh resulted in a reduction of
ubiquitinated Smo (Figure 3A, compare lanes 2–3 to lane 1, top
panel), indicating that Hh down-regulated Smo ubiquitination.
We also found that the treatment of cells with ammonium chloride
(NH4Cl), a lysosomal inhibitor, increased both the ubiquitination
(Figure 3A, compare lane 4 to lane 1, top panel) and total protein
(Figure 3A, compare lane 4 to lane 1, upper-middle panel) levels of
Smo, suggesting that the lysosome may mediate the degradation of
ubiquitinated Smo. These results are consistent with the finding
that Smo accumulates in the lysosome in the absence of Hh [16].
Treatment with Hh followed by NH4Cl dramatically reduced Smo
Author Summary
The Hedgehog (Hh) signaling pathway is well known for its
role in directing processes such as cell growth, prolifera-
tion, and differentiation during embryogenesis. The signal
initiated by Hh binding to its receptor, Patched, is
transduced by another protein called Smoothened (Smo),
which moves from membranes inside the cell to accumu-
late on the cell surface when Hh binds. This accumulation
of Smo on the cell surface is thought to play a central role
in maintaining Hh signaling. In this study, we investigated
how Hh controls the stability and movement of Smo inside
the cell. We found that Smo is modified by addition of a
small protein called ubiquitin (Ub), and that Hh regulates
the ubiquitination of Smo. We identified an enzyme called
USP8 that can remove the ubiquitin modification from
Smo, thereby enhancing its signaling activity. Furthermore
we show that Hh can enhance the interaction between
Smo and USP8. Finally, we discovered that USP8 promotes
the movement of Smo from inside the cell to the cell
surface. We conclude that Hh promotes the deubiquitina-
tion of Smo by USP8, resulting in the relocation of Smo to
the cell surface where it enhances Hh signaling.
USP8 Deubiquitinates Smo
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Figure 2. Addition of Ub to the C-terminus of Smo attenuates the signaling activity of Smo. (A) A wild-type adult wing indicates the five
interveins. (B–D) Wings expressing Myc-Smo, Myc-SmoUb, or Myc-SmoCFP at the 75B1 attP locus by MS1096 Gal4 to ensure equal expression of each
individual constructs. The arrows in (B) and (D) indicate the extra wing structures in the anterior compartment of the wing, which is indicative of
anterior ectopic Hh activity that is caused by the expression of wild-type Myc-Smo or Myc-SmoCFP. The wing in (C) shows the wild-type structure,
which indicates that the activity of Myc-SmoUb is lower than that of Myc-Smo or Myc-SmoCFP. (E–F) S2 cells were transfected with RFP-Rab7 and
GFP-Smo or GFP-SmoUb followed by immunostaining with Rab5 antibody to label the early endosomes. Late endosomes are labeled by RFP-Rab7.
GFP indicates the expression and localization of Smo. The images shown in (E–F) are from intensity projection over the z-axis. (G) The percentage of
Smo that co-localized with Rab5 or Rab7 compared to the total amount of Smo (GFP puncta) calculated from (E–F) (n$10). More GFP-SmoUb puncta
were localized in Rab7-labeled late endosomes compared to GFP-Smo. (H) S2 cells were transfected with Myc-Smo, Myc-SmoUb, or Myc-SmoCFP. Cell
extracts were immunoprecipitated with the anti-Myc antibody and blotted with the anti-Myc antibody to examine the levels of Smo. GFP served as a
transfection and loading control. Of note, the stability of Myc-SmoUb is much lower than that of Myc-Smo or Myc-SmoCFP. (I) S2 cells were
transfected with Myc-Smo, Myc-SmoUb, or Myc-SmoCFP followed by treatment with or without Hh. Cell extracts were subjected to
immunoprecipitation and Western blot with the anti-Myc antibody to detect the levels of Smo. Note that Hh stabilizes Myc-Smo (lane 2, top
panel) but not Myc-SmoUb (lane 4, top panel). GFP served as a transfection and loading control.
doi:10.1371/journal.pbio.1001238.g002
Figure 1. Multi-monoubiquitination of Smo in Drosophila S2 cells. (A) S2 cells were transfected with Myc-Smo alone or in combination with
HA-Ub, followed by immunoprecipitation and Western blot analysis with the indicated antibodies. A blank vector was used as the
immunoprecipitation control, GFP as the transfection control, and IgG as the loading control. (B) Myc-Smo was transfected in S2 cells with or
without HA-Ub followed by immunoprecipitation and Western blot with the indicated antibodies. The expression of HA-Ub did not cause any
changes in the levels of Smo ubiquitination. The levels of HA-Ub are comparable to the levels of free Ub detected by P4D1 (bottom panel). (C) Myc-
Smo was co-transfected with HA-Ub or with each individual HA-tagged Ub mutant, followed by immunoprecipitation and Western blot analysis. HA-
Ub and Ub mutants gave rise to a similar smear pattern (top panel).
doi:10.1371/journal.pbio.1001238.g001
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Figure 3. Smo ubiquitination is regulated by Hh and phosphorylation. (A) S2 cells were transfected with Myc-Smo and treated with 30%
(lanes 2 and 5) or 60% (lanes 3 and 6) of Hh-conditioned medium or control medium (lanes 1 and 4), followed by treatment with or without NH4Cl.
Cell extracts were immunoprecipitated and a Western blot was performed with the indicated antibodies. IgG served as a loading control and GFP was
used as the transfection control. The arrow indicates hyperphosphorylated forms of Smo and the arrowhead indicates hypophosphorylated and
unphosphorylated forms. (B) Sequential treatments with Hh and lysosomal inhibitor induce differential ubiquitination of Smo. S2 cells were
transfected with Myc-Smo and treated with either Hh or the lysosomal inhibitor NH4Cl alone, or in combinations of Hh and NH4Cl treatment,
followed by immunoprecipitation and Western blot with the indicated antibodies to examine the ubiquitination levels of Smo. The following
treatments were performed: lane 1, control; lane 2, treatment with NH4Cl at a final concentration of 10 mM for 24 h; lane 3, treatment with 60% HhN-
conditioned medium for 24 h; lane 4, treatment with NH4Cl at the concentration of 10 mM for the first 6 h, then adding 60% of the volume of HhN-
conditioned medium, keeping NH4Cl at a final concentration of 10 mM for 18 h; lane 5, treatment with 60% volume of HhN-conditioned medium for
the first 6 h, then adding NH4Cl at final concentration of 10 mM, keeping 60% volume of Hh medium for 18 h; lanes 6 and 7, HhN cDNA was
cotransfected to achieve higher levels of Hh treatment. Consistently, Hh treatment down-regulates (lane 3, top panel) whereas NH4Cl treatment up-
regulates (lane 2, top panel) Smo ubiquitination. However, Hh treatment down-regulates Smo ubiquitination before NH4Cl treatment (lane 5, top
panel), but not after NH4Cl treatment (lane 4, top panel). The further down-regulation of Smo ubiquitination by Hh was achieved by cotransfecting
Hh cDNA (lane 6, compared to lane 3). (C) NIH3T3 cells were transfected with Myc-hSmo and treated with or without recombinant Shh. Shh induced a
marked decrease in hSmo ubiquitination (lane 3). (D) HEK293T cells were transfected with the indicated constructs and cell extracts were
immunoprecipitated and blotted with the indicated antibodies. Cell lysates were also subjected to direct Western blot to examine the HA-tagged Ub
expression. GFP served as transfection and loading control. Human Smo had a similar multi-mono ubiquitination pattern compared to fly Smo. (E) S2
cells transfected with Myc-Smo were treated with Hh-conditioned medium or control medium in combination with a PKA inhibitor (H-89) or CK1
inhibitor (CK1-7). Immunoprecipitation and Western blots were performed with the indicated antibodies. The levels of ubiquitinated Smo were
increased by inactivating kinases. (F) S2 cells were transfected with wild-type, phospho-mimetic, or phospho-deficient Smo followed by treatment
with Hh-conditioned medium or control medium. The same ubiquitination assay was carried out to examine ubiquitinated Smo with IgG and GFP
serving as controls.
doi:10.1371/journal.pbio.1001238.g003
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ubiquitination (Figure 3A, lanes 5–6, top panel; Figure 3B, lanes 5
and 7, top panel), whereas treatment with NH4Cl followed by Hh
had very little effect on Smo ubiquitination (Figure 3B, lane 4, top
panel). These data suggest that Hh likely down-regulates Smo
ubiquitination before Smo enters the lysosome. The Hh-induced
mobility shifts and stabilization of Myc-Smo (Figure 2A, upper-
middle panel; Figure 2B, middle panel) are consistent with our
previous findings [12,30,31].
To determine if mammalian Smo is regulated by ubiquitination,
we transfected NIH3T3 cells with Myc-tagged human Smo (Myc-
hSmo) and performed a similar immunoprecipitation assay as
used for Drosophila S2 cells. We found that hSmo underwent
ubiquitination, which was detected by the P4D1 antibody
(Figure 3C, lane 2, top panel). In addition, Shh treatment induced
a substantial decrease in hSmo ubiquitination (Figure 3C, lane 3,
top panel). To examine whether hSmo is also multi-monoubiqui-
tinated, we performed an immunoprecipitation assay in
HEK293T cells transfected with Myc-hSmo and HA-Ub con-
structs. We found that Myc-hSmo pulled bound both HA-Ub and
HA-UbK0 in a similar pattern (Figure 3D, top panel). These data
suggest a conserved mechanism that regulates mammalian Smo.
It has previously been shown that Hh-induced phosphorylation
by PKA and CK1 promotes Drosophila Smo cell-surface accumu-
lation and signaling activity [11–13]. Our data suggested that Hh
prevents Smo ubiquitination and that ubiquitination may down-
regulate Smo activity, so we therefore investigated whether there
was any relationship between Smo phosphorylation and ubiqui-
tination. As shown in Figure 2E, the Hh-induced reduction of Smo
ubiquitination was compromised by treatment with H-89 or CK1-
7, which are inhibitors of PKA and CK1, respectively (Figure 3E,
compare lanes 3, 4, or 5 to lane 2, top panel). Consistently,
mutating the main isoform of PKAc in wing disc attenuated Smo
accumulation and elevated the levels of protein ubiquitination
(Figure S1) [12]. We further found that a Smo phospho-mimetic
mutation (SmoSD123) that had mutations in the PKA and CK1
phosphorylation sites [12] had higher levels of Smo protein but
markedly lower levels of Smo ubiquitination (Figure 3F, compare
lane 3 to lane 1, top panel), whereas the phosphorylation-deficient
form of Smo (SmoPKA123) had lower levels of Smo protein but
higher levels of Smo ubiquitination (Figure 3F, compare lane 5 to
lane 1, top panel). Moreover, Hh down-regulated the ubiquitina-
tion of Smo variants (Figure 3F, top panel), suggesting that
phosphorylation at other sites in the Smo C-tail [13] could
counteract further ubiquitination of Smo. Taken together, our
observations suggest that phosphorylation antagonizes ubiquitina-
tion in the regulation of Smo.
Identification of a Deubiquitinase for Smo by an RNAi
Screen
Ubiquitin ligases and DUBs play opposing roles in the
regulation of protein ubiquitination. To explore whether DUBs
were involved in the regulation of Smo, we obtained 45 RNAi
lines from the Vienna Drosophila RNAi Center (VDRC), which
target 33 potential DUBs in the Drosophila genome (Table S1)
[32,33], and performed an in vivo screen by overexpressing
individual RNAi lines through the wing-specific MS1096 Gal4 to
assess for the induction of an adult wing phenotype. The screen
showed that RNAi-mediated knockdown of 11 genes affected wing
development, as indicated by wing phenotypes or wing blisters
(Table S1; unpublished data). Since it was possible that a specific
DUB may reduce Smo ubiquitination and cause changes in Smo
accumulation, we immunostained the wing imaginal discs using an
anti-SmoN antibody when the expression of each of the 11 DUB
genes was knocked down by RNAi. Expression of UAS-RNAi lines
that targeted USP8 caused a reduction in Hh-induced Smo
accumulation in P-compartment cells. Moreover, the expression of
Hh target genes, such as ptc, was attenuated in the dorsal
compartment cells where the ap-Gal4 was expressed. We also
examined the levels of Smo ubiquitination in S2 cells when the
expression of each of the 11 DUBs was knocked down by RNAi.
As shown in Figure 4A, inactivation of USP8 in S2 cells by RNAi
dramatically enhanced the levels of Smo ubiquitination (Figure 4A,
lane 4, compare to lane 2, top panel), whereas the reduction of
other DUBs by RNAi did not, suggesting that the inhibition of
Smo accumulation by USP8 RNAi in wing discs was due to the
increase in Smo ubiquitination. We then overexpressed Myc-Smo
with each of the DUBs in S2 cells and performed an
immunoprecipitation assay to examine the levels of Myc-Smo
ubiquitination. As shown in Figure 4C, USP8, but not the other
DUBs, reduced the ubiquitination of Myc-Smo. Together, these
data suggest that USP8 is a specific DUB for Smo.
DUBs have a highly conserved motif (GNTCYMNS) in the
catalytic domain, and mutation of the catalytic Cys in this
sequence often leads to an inactive form of the enzyme [33]. To
further examine the role of USP8 in Smo regulation, we generated
a Flag-tagged USP8 mutant with Cys572 changed to Ser (Flag-
USP8C.S) and co-transfected Myc-Smo with Flag-USP8C.S,
Flag-USP8, or USP8 dsRNA in S2 cells. Overexpression of Flag-
USP8 in S2 cells reduced Smo ubiquitination (Figure 4B, lane 3,
top panel), whereas knockdown of USP8 by RNAi enhanced the
levels of ubiquitinated Smo (Figure 4B, lane 2, top panel), which
was consistent with the data from the screen. We also found that
the overexpression of Flag-USP8C.S did not reduce Smo
ubiquitination (Figure 4B, lane 4, top panel), suggesting that
USP8C.S was an inactive enzyme. In contrast, USP8C.S
increased Smo ubiquitination, which was similar to the phenotype
induced by the RNAi-mediated knockdown of USP8 (Figure 4B,
lanes 2 and 4, compare to lane 1, top panel). These results
suggested that USP8C.S may have a dominant negative effect on
endogenous USP8. In agreement with this hypothesis, the
overexpression of HA-USP8 reversed the effects of Flag-
USP8C.S and again reduced the levels of ubiquitinated Smo
(Figure 4D, lane 4, top panel). These results were consistent with
the previous finding that a consensus Cys mutation in USP8
caused dominant negative effects in cultured vertebrate cells [34].
USP8 Regulates Smo Ubiquitination
To determine whether USP8 has a role in the Hh-mediated
reduction of Smo ubiquitination, we examined Smo ubiquitination
when USP8 was inactivated. As shown in Figure 5A, Smo
ubiquitination was consistently reduced by Hh treatment
(Figure 5A, lane 2, top panel). However, the reduction of Smo
ubiquitination was not observed when USP8 was knocked down
by RNAi or inactivated by expressing USP8C.S (Figure 5A, lanes
3 and 5, top panel). In contrast, overexpression of Flag-USP8
caused a greater reduction in Smo ubiquitination (Figure 5A, lane
4, top panel). These data suggest that USP8 is required for the Hh-
induced reduction of Smo ubiquitination. We also wondered
whether USP8 regulates the ubiquitination of SmoSD123. We
found that when SmoSD123 was co-expressed with Flag-USP8, the
level of Smo ubiquitination was reduced, whereas when SmoSD123
was co-expressed with USP8RNAi or Flag-USP8C.S, the levels
of Smo ubiquitination were increased (Figure 5B). These results
suggested that the ubiquitination of SmoSD123 can be regulated by
USP8.
To test whether USP8 regulates Smo ubiquitination by
interacting with Smo, we carried out co-immunoprecipitation
experiments and found that Myc-SmoCT (Smo C-tail), but not
USP8 Deubiquitinates Smo
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Figure 4. Identification of USP8 as a DUB for Smo. (A) S2 cells were transfected with Myc-Smo and treated with the indicated DUB dsRNA,
followed by immunoprecipitation with an anti-Myc antibody and Western blot with the P4D1 antibody to examine the levels of Smo ubiquitination.
(B) Myc-Smo was transfected either alone or in combination with Flag-USP8, Flag-USP8C.S, or USP8 dsRNA treatment. The immunoprecipitation
assay was performed to examine the amount of ubiquitinated Smo. The efficiency of USP8 RNAi was examined with the anti-USP8 antibody. The
arrowhead indicates transfected USP8 and the arrow indicates endogenous USP8. Notably, USP8 RNAi and USP8C.S severely destabilized Smo,
whereas USP8 stabilized Smo in S2 cells. (C) S2 cells were transfected with Myc-Smo and the indicated DUB constructs followed by
immunoprecipitation with the anti-Myc antibody and Western blot with the anti-Ub P4D1 antibody. Flag-USP8, but not other DUBs, reduced Smo
ubiquitination (lane 3, compared to lane 2, top panel). Cell lysates were also subjected to Western blot to examine the expression of different DUBs
(bottom panel). (D) S2 cells were transfected with the indicated constructs and an immunoprecipitation assay was performed to detect Smo
ubiquitination. The asterisks in (B) and (D) show a possible modification on USP8C.S, which was down-regulated by the co-transfection of USP8,
suggesting the possibility of ubiquitination.
doi:10.1371/journal.pbio.1001238.g004
USP8 Deubiquitinates Smo
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Myc-SmoCT (Smo lacking its C-tail), co-immunoprecipitated with
HA-USP8 (Figure S2B). To further map the Smo domain
responsible for interacting with USP8, we tested various SmoCT
truncations, which were previously generated (Figure 5C) [30], for
their ability to bind USP8. We found that amino acids 625–753 of
Smo were responsible for the interaction with USP8 (Figure 5C,
unpublished data).
Hh might prevent Smo ubiquitination by regulating the DUB.
However, it is unlikely that USP8 activity per se is regulated by
Hh, as USP8 has been shown to be involved in multiple signaling
pathways. The finding that USP8 interacted with Smo led to the
hypothesis that Hh might control the accessibility of Smo to the
DUB. To test this, we used a GST pull-down assay previously
described [30]. We found that GST-Smo625-753 pulled down
more Flag-USP8 in the presence of Hh (Figure 5D, lane 3, top
panel) than that in the absence of Hh, suggesting that Hh regulates
the accessibility of USP8 to Smo. We also found that phosphor-
mimetic mutation in GST-Smo enhanced its interaction with
USP8 (Figure 5E, lane 2, top panel). In addition, we found, in an
immunoprecipitation experiment, that a substantial amount of
SmoSD123 interacted with USP8 (Figure 5F, lane 2, top panel). In
contrast, SmoPKA123 barely interacted with USP8 (Figure 5F, lane
3, top panel). These data suggest that phosphorylation of Smo
promotes the formation of a Smo-USP8 complex, which may
amplify the Hh stimulation and lead to the activation of Smo.
To better address the relationship between phosphorylation and
deubiquitination, we used a newly developed phospho-Smo
antibody to specifically detect Smo phosphorylation at the 2nd
cluster (anti-SmoP, Fan et al., unpublished). We found that USP8
stabilized Smo (Figure 5G, lane 2, compared to lane 1, top panel),
but neither promoted Smo mobility shift on the gel (Figure 5G,
lane 2, top panel) nor induced Smo phosphorylation (Figure 5G,
lane 2, upper middle panel). Consistently, Hh induced Smo
phosphorylation, which was detected by the mobility shift and the
anti-SmoP antibody (Figure 5G, lane 3, top and upper middle
panels). Interestingly, in the presence of Hh and USP8, Smo gave
rise to a peak level of phosphorylation (Figure 5G, lane 4, top and
upper middle panels). These observations suggest that USP8 does
not primarily regulate Smo phosphorylation but promotes Smo
phosphorylation when Hh is present.
USP8 Promotes Smo Accumulation in Wing Imaginal
Discs
We next performed both loss- and gain-of-function studies in
wing discs to examine the regulation of Smo accumulation by
USP8. We found that the dominant negative USP8C.S blocked
Smo accumulation in P-compartment cells (Figure 6C) and
attenuated ptc-lacZ expression (Figure 6D), which is a phenotype
similar to that caused by RNAi of USP8 (Figure 6B–B0). To
further examine the physiological function of USP8 in regulating
Smo, we also used an usp8 hypomorphic allele, usp8KO, that has
been previously described in the literature [28]. Smo accumulation
was severely reduced in usp8KO cells (Figure 6E), and pupa bearing
usp8KO clones were lethal (unpublished data). These loss-of-
Figure 5. USP8 regulates Smo ubiquitination. (A) S2 cells
transfected with Myc-Smo in combination with the indicated USP8
constructs or with USP8 dsRNA treatment were treated with Hh-
conditioned medium or control medium. An immunoprecipitation
assay was carried out with the indicated antibodies to examine the
regulation of Smo ubiquitination by Hh or USP8. In the above
experiments, GFP served as a transfection and loading control. (B) S2
cells were transfected with Myc-SmoSD123 alone or in combination
with either Flag-USP8, Flag-USP8C.S, or USP8 dsRNA treatment. Cell
extracts were immunoprecipitated with the anti-Myc antibody and
subjected to a Western blot with the anti-Ub P4D1 antibody to detect
ubiquitinated Smo (top panel), or with the anti-Myc antibody to detect
the expression of Myc-SmoSD123 (upper-middle panel). Cell lysates were
also subjected to a direct Western blot with the anti-Flag antibody to
detect USP8 or USP8C.S overexpression (lower-middle panel) or with
the anti-Ub P4D1 antibody to detect the overall level of Ub (bottom
panel). The asterisk indicates a possible modification of USP8C.S. USP8
reduced SmoSD123 ubiquitination, whereas USP8C.S enhanced
SmoSD123 ubiquitination. The asterisks in (A) and (B) show a possible
modification on USP8C.S. (C) The interaction between Smo fragments
and USP8 was determined in S2 cells. Briefly, S2 cells were co-
transfected with Flag-USP8 and each Myc-Smo construct followed by
immunoprecipitation with the anti-Myc antibody and Western blot with
anti-Flag antibody to detect the Smo-bound USP8. Smo1-555 (N-
terminal part of Smo) did not interact with USP8 (not shown). The +/2
indicates a weak interaction. (D) Hh up-regulates Smo-USP8 interaction.
Extracts from S2 cells expressing Flag-USP8 with or without Hh
treatment were incubated with the bacterially expressed GST or GST-
Smo625-753 fusion proteins. The bound USP8 proteins were analyzed
by Western blot with the anti-Flag antibody. The middle panel shows
the GST and GST-Smo fusion proteins. The lower panel indicates the
equal amount of input USP8. (E) The interaction between Flag-USP8
and GST-Smo625-753, GST-Smo625-753SD123 (GST-SmoSD, with PKA and
CKI1 sites mutated to Asp), and GST-Smo625-753PKA123 (GST-SmoSA,
with PKA sites mutated to Ala). (F) S2 cells were co-transfected with HA-
USP8 and wild-type, phospho-mimetic, or phospho-deficient Smo,
followed by immunoprecipitation and Western blot analysis to examine
the interaction between Smo and USP8. GFP served as a transfection
and loading control. (G) S2 cells were transfected with Myc-Smo alone
or in combination with Flag-USP8 and treated with Hh-conditioned
medium or control medium. Cell extracts were immunoprecipitated
with the anti-Myc antibody and blotted with either anti-Myc to detect
Smo phosphorylation, indicated by its mobility shift on the SDS gel, or
anti-SmoP, to directly detect Smo phosphorylation. The overexpression
of USP8 increased the level of Smo without any effect on Smo
phosphorylation. GFP served as a transfection and loading control.
doi:10.1371/journal.pbio.1001238.g005
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function studies indicate that USP8 is required for Smo
accumulation. In addition, a gain-of-function experiment showed
that the overexpression of USP8 caused an accumulation of Smo
in both A- and P-compartment cells (Figure 6F) and caused
anterior expansion of ptc-lacZ in cells that received Hh (Figure 6G).
Moreover, inactivation of USP8 by either USP8RNAi or
USP8C.S in Drosophila embryo down-regulated En expression
(Figure 6I–J, compare to wild-type En staining in H) and caused
lethality of the embryo or pupa (unpublished data). We also
examined the expression pattern of endogenous USP8 transcrip-
tion by in situ hybridization and found that USP8 was highly
expressed in the wing pouch that is more sensitive to Hh signaling
(Figure 6K–K0). Our observations strongly suggested that USP8
has a positive role in Hh-induced Smo accumulation, which is
likely due to the role in regulating Smo ubiquitination.
Our previous study showed that overexpression of UAS-Smo by
MS1096 Gal4 caused albeit low levels of ectopic Hh pathway
activation in the anterior compartment of the wing discs [35],
Figure 6. The function of USP8 in regulating Smo accumulation in the Drosophila wing. (A–A0) A wing disc expressing UAS-GFP by the
dorsal compartment-specific ap-Gal4 was stained for Smo and ptc-lacZ to show the wild-type staining. (B–B0) A wing disc from flies co-expressing
UAS-USP8RNAi and UAS-GFP by ap-Gal4 was stained for Smo and ptc-lacZ. The arrow in (B) indicates the attenuated accumulation of Smo and the
arrowheads indicate the down-regulation of ptc-lacZ. GFP indicates that ap-Gal4 is expressed in the dorsal compartment cells of the wing disc. (C–D)
Wing discs expressing UAS-Flag-USP8C.S by MS1096 Gal4 were stained for Smo (grey in C), Flag (green in C9), and ptc-lacZ (red in D). The arrow in (C)
indicates inhibition of Smo accumulation. The arrow in (D) indicates attenuated ptc-lacZ expression. Note that the level of Gal4 driven by MS1096 is
higher in the dorsal compartment than in the ventral compartment. (E–E0) A wing disc bearing usp8KO homozygous clones, which were marked by
the lack of b-gal staining, was immunostained for Smo. The arrow in (E) shows the reduced Smo accumulation in P-compartment cells. (F–G) Wing
discs expressing UAS-Flag-USP8 by MS1096 Gal4 were stained for Smo (grey in F), Flag (green in F9), and ptc-lacZ (red in G). Arrow and arrowhead in
(F) indicate the elevated Smo and arrow in (G) indicates the expansion of ptc-lacZ. (H) A wild-type embryo was stained for En. (I–J) Embryos
expressing USP8RNAi or USP8C.S by act5C-Gal4 were immunostained for En. The arrowheads indicate the reduction and contraction of En
expression. (K–K0) USP8 expression patterns in wing and leg discs (arrow and arrowhead, respectively) were determined by FISH with a DIG-labeled
mRNA probe against USP8. Rhodamin (red) was used to detect the DIG-labeled mRNA, and DAPI (green, was false colored in green to provide better
contrast) was used to label the nuclei. All wing imaginal discs shown in this study were oriented with anterior on the left and ventral on the top. (L) A
wild-type adult wing showing interveins 1–5. (M–N) Wings from either male or female flies expressing Flag-Smo by MS1096 Gal4. The arrow in (M)
indicates the overgrowth structures between Vein 2 and 3, and the arrow in (N) indicates the thickened Vein 3 caused by the overexpression of Smo.
(O) A wing from flies expressing USP8RNAi by MS1096 Gal4. (P–Q) Wings from male or female flies expressing Flag-USP8 by MS1096 Gal4. Arrows
indicate the wing overgrowth structure or the thickness of Vein 3. Of note, males of the same genotype have more severe phenotypes than females,
presumably due to dosage compensation of the X-chromosome carrying the MS1096-Gal4. (R) A wing from ptc mutant flies indicates the overgrowth
between Vein 2 and 3. (S–T) Adult wings from flies expressing Flag-USP8 by MS1096 Gal4 in the background of ptc mutants. In the ptc heterozygous
or homozygous background, USP8 induced more severe wing overgrowth, which is indicated by wing blisters (S) or sick wings (T).
doi:10.1371/journal.pbio.1001238.g006
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which induced overgrowth of the structure between Vein 2 and
Vein 3 (Figure 6M, compare to a wild-type wing in 6L) or the
thickness of Vein 3 (Figure 6N). Here, we found that overexpres-
sion of USP8 caused similar phenotypes (Figure 4P–Q). RNAi-
mediated knockdown of USP8 severely disrupted the wing
morphology (Figure 6O) and USP8C.S expression caused a
more severe malformation of the wing as well as lethality of the
pupa (unpublished data). The wing phenotypes correlated with the
levels of Smo accumulation in wing discs where USP8RNAi,
USP8C.S, or USP8 was expressed (Figure 6B, C, and F),
suggesting that the adult wing phenotypes were caused, at least in
part, by USP8-mediated regulation of Smo. Overexpression of
USP8 elevated the level of Smo but did not induce ectopic Hh
signaling activity in A compartment cells located away from the
A/P boundary. This could be due to the inhibition of Smo by Ptc,
since it has been shown that ptc mutant clones situated in the A-
compartment of wing discs accumulate high levels of Smo [16]. To
test this possibility, we expressed Flag-USP8 in the ptc mutant
background and found that USP8 induced severe wing growth in
the ptc heterozygote (Figure 6S, compared to 6R) and caused sick
wings in the ptc homozygous background (Figure 6T). These
results suggest that the USP8-mediated elevation of Smo is still
inhibited by Ptc.
USP8 Promotes Smo Signaling Activity
Overexpression of USP8 caused an elevation of Smo in both A-
and P-compartment cells but did not ectopically activate Hh target
genes, such as ptc, in A-compartment cells located away from the
A/P boundary (Figure 6G). This could have been due to
insufficient levels of Smo. To test this possibility, we coexpressed
Flag-USP8 with GFP-Smo, a construct that had been developed in
an earlier study [35]. Co-expression of Flag-USP8 with GFP-Smo
by MS1096 Gal4 caused induction of dpp-lacZ and ptc expression in
A-compartment cells both close to and away from the A/P
boundary (Figure 7G–H), whereas the expression of Flag-USP8
alone did not induce ectopic dpp-lacZ and ptc expression
(Figure 7E–F). Moreover, the expression of GFP-Smo only
induced a low level of ectopic dpp-lacZ (Figure 7C) and no ectopic
ptc expression (Figure 7D) in cells located away from the A/P
boundary. Similar results were obtained when act.CD2.Gal4
was used to co-express Flag-USP8 with GFP-Smo, which
suggested a cell-autonomous regulation (Figure S1A–B9). We also
found that USP8 did not change the dominant negative activity of
SmoPKA123 in wing discs (unpublished data), suggesting that
phosphorylation and dimerization is required for Smo activation
even though Smo can be stabilized by deubiquitination.
We had previously shown that SmoSD123 has constitutive cell-
surface expression and signaling activity and is still regulated by
Hh [12]. To test whether USP8 regulated the activity of SmoSD123
in vivo, SmoSD123 was expressed either alone or together with
USP8RNAi and the expression of ptc-lacZ and en were examined.
As shown in Figure 7N–O9, SmoSD123 showed constitutive
signaling activity and induced the ectopic expression of ptc-lacZ
and en. Knockdown of USP8 by RNAi attenuated the ectopic ptc-
lacZ expression (Figure 7O) and greatly reduced the ectopic
expression of en (Figure 7O9), which was likely due to the effect of
USP8 regulating SmoSD123 ubiquitination (Figure 5B). Similar
results were achieved by using act.CD2.Gal4 (Figure S1C–D9).
These data suggest that SmoSD123 underwent a low level of
ubiquitination, which prevents further activation.
The Function of USP8 Domains in Regulating Smo
To further assess the function of USP8 in the regulation of Smo
ubiquitination, we generated HA-tagged USP8 truncations and
assessed their effects on Smo ubiquitination as well as their
interaction with Smo in S2 cells (Figure 8A). The catalytic domain
of USP8 (USP8NT3) was sufficient to reduce Smo ubiquitination
(Figure 8B, lane 4, top panel), enhance the accumulation of
endogenous Smo (Figure 8D), and increase the GFP-Smo-
mediated induction of ectopic dpp-lacZ and ptc expression
(Figures 7K–L, S1E–E90). Similar to USP8, USP8NT3 alone did
not induce any ectopic activation of Hh signaling in cells away
Figure 7. USP8 promotes Smo signaling activity. (A–B) Wild-type wing discs were stained with anti-b-Gal and anti-Ptc antibodies to show dpp-
lacZ and endogenous Ptc expression, respectively. (C–L) Wing discs expressing GFP-Smo alone (C–D), Flag-USP8 alone (E–F), GFP-Smo and Flag-USP8
together (G–H), HA-USP8NT3 alone (I–J), or GFP-Smo and HA-USP8NT3 together (K–L) by MS1096 Gal4 were stained for dpp-LacZ or Ptc. The red
arrows indicate the ectopic expression of either dpp-lacZ or Ptc. (M–M9) A wild-type wing disc was immunostained for ptc-lacZ and En. (N–O9) Wing
discs expressing SmoSD123 alone or together with USP8RNAi by MS1096 Gal4 was immunostained for ptc-lacZ and En. Knockdown of USP8 by RNAi
attenuated the ectopic ptc-lacZ expression (arrow in O) and greatly reduced the ectopic en expression (arrow in O9).
doi:10.1371/journal.pbio.1001238.g007
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from the A/P boundary (Figure 7I–J). We also examined the
activity of USP8 mutants that contain the Cys572Ser mutations.
Both USP8C.S and USP8NT1C.S had dominant negative
effects, but USP8NT2C.S and USP8NT3C.S did not
(Figure 8C). In addition, USP8NT3C.S had no effect on Smo
accumulation in wing discs (Figure 8E–E9) or on GFP-Smo activity
(unpublished data). These data suggest that the MIT and RHOD
domains are required for USP8C.S to act in a dominant negative
manner. We further examined the subcellular localization of USP8
variants and found that USP8C.S and USP8NT1C.S, but not
Figure 8. The deubiquitinase activity of USP8 variants. (A) A diagram of the USP8 protein and deletion constructs. The interaction between
Smo and USP8 was determined by immunoprecipitation experiments shown in Figure S2. The activity of each USP8 construct was assessed in S2 cells
by their ability to regulate the levels of Smo ubiquitination (shown below). MIT, microtubule interacting and transport domain; RHOD, Rhodanese
homology domain. (B) S2 cells were transfected with Myc-Smo and the indicated USP8 constructs followed by the immunoprecipitation assay to
detect Smo ubiquitination. The expression of USP8 variants was detected by a Western blot of lysates with an anti-Flag antibody (lower-middle
panel). The arrow indicates a non-specific band and the asterisks indicate a possible modification of USP8C.S or USP8NT3C.S. USP8NT3C.S and
USP8CT1 did not regulate Smo ubiquitination (lanes 5 and 6, top panel). (C) The effects of USP8 mutants on Smo ubiquitination were examined in S2
cells by the immunoprecipitation assay. The asterisks indicate a possible modification of USP8. Of note, both USP8C.S and USP8NT1C.S have
dominant negative effects on Smo ubiquitination (lanes 3 and 4, top panel), whereas USP8NT2C.S and USP8NT3C.S do not (lanes 5 and 6, top
panel). (D–E9) Wing discs expressing USP8NT3 or USP8NT3C.S by ap-Gal4 was immunostained for Smo and HA. The arrow and arrowhead in (D)
indicate elevated Smo accumulation in A- and P-compartment cells. Notably, expression of USP8NT3C.S has no effect on Smo accumulation.
doi:10.1371/journal.pbio.1001238.g008
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the other forms, were primarily localized to Rab5-labeled and
enlarged early endosomes, which was caused by the overexpres-
sion of these mutants (Figure 9). Rab5 is a small GTPase that is
often used as a marker of the early endosome [36]. The results
from the localization assay suggest that the N-terminal domains of
USP8 are responsible for its accumulation in the early endosome
and for the dominant negative activity.
We also carried out a series of immunoprecipitation experi-
ments with S2 cells to map the USP8 domain that is responsible
for the interaction with Smo. Collectively, the data showed that
USP8NT3 was responsible for the interaction with Smo
(Figures 8A and S2). Importantly, these results were in agreement
with the finding that the catalytic domain of USP8 was capable of
preventing Smo ubiquitination.
USP8 Regulates Hh-Induced Cell Surface Accumulation of
Smo
In the absence of Hh, Smo remains in an unphosphorylated or
hypophosphorylated state and can be removed from the cell
surface by endocytosis. To confirm this presumption, we examined
Smo levels in wing discs when the endocytosis machinery was
inactivated. Shibire (Shi) is the Drosophila homolog of the dynamin
GTPase that plays an essential role in regulating the internaliza-
tion and sorting of membrane proteins [37] and is required for Ptc
endocytosis [38]. We found that the accumulation of Smo was
elevated in wing discs expressing Shi RNAi (Figure 10A) or
expressing a dominant negative Shi (Shi-DN, Figure 10B),
suggesting that Smo may function through Shi-mediated endocy-
tosis. In addition, we found that the inactivation of Shi caused an
increase in Ci (Figure 10A9 and B9), which suggested that Shi has a
negative role in Hh signaling.
We next wished to assess whether the accumulation of Smo
induced by the overexpression of USP8 or the inactivation of Shi
was due to changes in the cell surface accumulation of Smo. CFP-
Smo was transfected into S2 cells that were treated with GFP
dsRNA (control), USP8 dsRNA, or Shi dsRNA and then treated
with Hh-conditioned medium or control medium. Consistent with
our previous observations [31], Hh stimulation causes the
accumulation of Smo on the cell surface in the presence of
control dsRNA (Figure 10D). Interestingly, the cell surface
accumulation of Smo was elevated by the RNAi-mediated
reduction of Shi (Figure 10E–F) or by the overexpression of
USP8 (Figure 10I–J) in both the presence and absence of Hh
stimulation. In contrast, the cell surface accumulation of Smo was
reduced by an RNAi-mediated reduction of USP8 (Figure 10H) or
by the overexpression of USP8C.S (Figure 10L) even in the
presence of Hh stimulation. Without Hh treatment, Smo cell
surface accumulation was barely detectable (Figure 10C, G, and
K). These data suggest that USP8 promotes the cell surface
accumulation of Smo, and that Shi mediates Smo endocytosis.
We have previously shown that SmoSD123 has constitutive cell
surface expression [12]. To examine if USP8 regulates the cell
surface accumulation of SmoSD123, we co-transfected CFP-
Figure 9. The localization of USP8 variants in S2 cells. S2 cells
were cotransfected with USP8 constructs and RFP-Rab5 followed by
immunostaining with an anti-HA antibody to label the expression of
USP8 constructs. Rab5 marks the early endosome. Of note, the
expression of USP8C.S and USP8NT1C.S causes enlarged early
endosomes, and both forms of USP8 localize in these enlarged early
endosomes. USP8, USP8NT1, USP8NT2, and USP8NT2C.S are evenly
distributed in the cytosol without a specific pattern. USP8NT3 behaves
like USP8NT2 and USP8NT3C.S behaves like USP8NT2C.S (unpub-
lished data).
doi:10.1371/journal.pbio.1001238.g009
Figure 10. USP8 is required for Hh-induced Smo cell surface
accumulation. (A–B9) Wing discs expressing UAS-ShiRNAi or UAS- Shi-
DNS (a strong line) by MS1096 Gal4 was stained for Smo and Ci. The
arrows indicate the RNAi-mediated increase in accumulation of Smo
and Ci. (C–O) CFP-Smo or CFP-SmoSD123 was transfected into S2 cells
and the cells were treated with GFP dsRNA, Shi dsRNA, USP8 dsRNA, or
Hh-conditioned medium. Smo that localized to the cell surface was
visualized by immunostaining with an anti-SmoN antibody before
membrane permeabilization. The total amount of expressed Smo was
indicated by the CFP signal. Representative images are shown here. (P)
Quantification analysis of the percentage of Smo on the cell surface
(mean 6 s.d.; n$15). Ratio (%) = (cell surface signal/whole cell
signal)6100.
doi:10.1371/journal.pbio.1001238.g010
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SmoSD123 with USP8 or USP8C.S in S2 cells. The cell surface
accumulation of SmoSD123 increased in the presence of USP8
(Figure 10N) and was reduced in the presence of USP8C.S or
USP8 RNAi (Figure 10O, unpublished data), which suggested that
the decrease in SmoSD123 activity (Figure S1D–D9) was due to the
attenuation of cell surface accumulation of SmoSD123. Consistent
with these data, the overexpression of USP8 reduced SmoSD123
ubiquitination, whereas the inactivation of USP8 increased Smo
ubiquitination (Figure 5B). The quantification analysis of Smo cell
surface accumulation further supported our findings (Figure 10P).
USP8 Prevents the Localization of Smo to the Early
Endosome
To determine whether the cell surface accumulation of Smo was
due to a change in subcellular localization, we performed an
antibody uptake assay with the anti-SmoN antibody to examine
whether internalized Smo co-localized with Rab5. We hypothe-
sized that blocking endocytosis may decrease Smo localization to
the early endosomes, while inhibiting Smo recycling may lead to
an accumulation of Smo in the early endosomes. As shown in
Figure 11B, 99% of the internalized Smo protein co-localized with
Rab5 positive particles, which occupied nearly 70% of the
endosomes (Figure 11B). We also found that Hh treatment
inhibited Smo endocytosis and reduced the ratio of Rab5-localized
Smo (Figure 11C), which was consistent with our previous
observation that Smo internalization is largely inhibited by Hh
[12]. In addition, most SmoSD123 was not internalized (unpub-
lished data). Therefore, Hh treatment and phosphorylation of Smo
likely blocked Smo endocytosis. Moreover, Shi RNAi attenuated
the localization of Smo in the early endosomes (Figure 11D),
whereas USP8 RNAi elevated the localization (Figure 11E). The
overexpression of USP8 decreased the amount of Smo that co-
localized with Rab5 (Figure 11F), which suggested that USP8 may
prevent the accumulation of Smo in early endosomes and
therefore promote the cell surface accumulation of the protein
(Figure 10I–J) as well as increase the signaling activity (Figure 7G–
H). We also found that inactivation of USP8 by RNAi or by
USP8C.S overexpression caused an enlargement of the early
endosome (Figure 11E and Figure 9), which was consistent with a
previous finding that USP8 deficient mouse primary cells exhibit
enlarged early endosomes [29]. In addition, quantification of the
amount of Smo that co-localized with Rab5 supported these
conclusions (Figure 11G). Taken together, our data suggest that
USP8 up-regulates the cell surface accumulation and signaling
activity of Smo by deubiquitinating the protein (Figure 11H).
Discussion
Smo is a key Hh signal transduction molecule located on the
plasma membrane and there is a good correlation between the cell
surface accumulation and signaling activity. However, little is
known regarding the dynamic activation of Smo or the factors that
regulate Smo trafficking. The present study has established that
the multi-monoubiquitination of Smo is a reversible process that is
impeded by an upstream signal. Moreover, this work has shown
that a specific deubiquitinase inhibits Smo ubiquitination. Using
an RNAi screen in both the Drosophila wing and cultured cells, we
identified and characterized USP8 as the DUB that is required for
Smo deubiquitination, accumulation, and activity.
Smo Ubiquitination
In this study, we have uncovered that Smo is multi-
monoubiquitinated and that the ubiquitination of Smo is reduced
by Hh. However, it is currently unknown how Smo is
Figure 11. USP8 prevents Smo localization in the early
endosome. (A) Illustration of the antibody uptake experiment. The
red arrowheads indicate the route of the endocytosed anti-SmoN
antibody. (B–F) S2 cells were transfected with CFP-Smo and treated
with (B) control medium, (C) Hh-conditioned medium, (D) Shi dsRNA, (E)
USP8 dsRNA, or (F) co-transfected with HA-USP8. The images shown
here are from intensity projection over the z-axis. Hh largely inhibited
the endocytosis of Smo, as indicated by the co-localization of Rab5 and
SmoN (C). Reduction of Shi by RNAi and overexpression of USP8 have
similar effects in the prevention of Smo localization in the early
endosomes that are labeled by Rab5 staining (D and F). Knockdown of
USP8 by RNAi caused the accumulation of Smo in enlarged early
endosomes (E). Rab5 positive endosomes were identified based on Z-
series confocal images of S2 cells stained with anti-Rab5 antibody. (G)
The percentage of Smo that co-localized with Rab5 (SmoN staining)
compared to the total amount of Smo (CFP signal) calculated from (B–F)
(n$10). (H) A model for Smo trafficking. USP8 is required for the Hh-
induced cell surface accumulation of Smo. Hh blocks Shi-mediated Smo
endocytosis. USP8 prevents Smo localization in the early endosome by
deubiquitinating Smo, and promotes Smo phosphorylation and
activation.
doi:10.1371/journal.pbio.1001238.g011
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ubiquitinated. Both Drosophila and vertebrate Smo contain
multiple Lys residues that are highly conserved among various
species [39], but it is not clear whether these residues can act as
linkages for Ub. In an effort to characterize Smo ubiquitination,
we mutated many of the conserved Lys residues in Smo C-tail and
examined their ubiquitination by an immunoprecipitation assay
and tested in vivo activities by expressing them at the equivalent
levels in wing discs. However, we did not observe any changes in
ubiquitination or activity (unpublished data). It is likely that
monoubiquitination occurs at many sites on Smo, which requires
the simultaneous mutation of most sites in order to detect an
ubiquitination change.
In regards to the ubiquitination pattern of Smo, although multi-
monoubiquitination is probably the predominant form, poly-
ubiquitination may still occur. In fact, Li et al. (this issue) found
that a small fraction of Smo was poly-ubiquitinated, which
promoted Smo degradation through the proteasome, suggesting
that Smo underwent both multi- and poly-ubiquitination. The
specific factors, such as ubiquitin ligase(s), involved in Smo
ubiquitination are also unknown. Identification of these pathway
components may explain why Smo is either multi-monoubiquiti-
nated or poly-ubiquitinated under different circumstances.
Although the loss-of-function of USP8 can block Hh-induced
cell surface accumulation of Smo, we found that USP8 only
stabilizes Smo but does not regulate Smo phosphorylation in the
absence of Hh (Figure 5G), suggesting that the regulation of Smo
by USP8 is downstream of Smo phosphorylation. Consistent with
this idea, we found that the phospho-mimetic SmoSD123 was still
regulated by USP8 (Figures 5B, 7O–O9, 10N–O, S1D–D9). USP8
likely plays an additional role in blocking Smo degradation.
However, based on our current knowledge and available tools, we
cannot clearly separate these roles of USP8 in regulating Smo.
It has been shown that the Smo C-tail mediates binding with
Cos2, Fu, and PP4 [30,35,40–42]. In this study, we add USP8 as
another protein that binds to the Smo C-tail region between
amino acids 625–753, which includes the three PKA and CK1
phosphorylation clusters. It is likely that phosphorylation at this
region promotes the binding of USP8. In support of this notion,
we found that Hh promotes the interaction between Smo and
USP8 (Figure 5D). We further found that a phospho-mimetic
mutation of Smo promotes its binding with USP8 (Figure 5E–F).
Previously, we created a deletion in Smo to avoid protein binding
and found that it affected the in vivo activity of Smo [30]. One
would expect that deletion of the USP8 binding domain may lead
to hyper-ubiquitination and thus inactivation of Smo, because this
binding domain contains the phosphorylation clusters that are
essential for Smo activation. However, there may be ubiquitina-
tion sites within this region, and we have not as yet identified the
ubiquitination residues in Smo.
Smo Cell-Surface Accumulation and Subcellular
Trafficking
Phosphorylation of Smo has been shown to be a crucial protein
modification event for the activation of Smo in response to Hh. In
this study, we found a role of ubiquitination in Smo trafficking
inside the cell by demonstrating that the removal of Ub from Smo
prevents localization of the protein to early endosomes, and the
addition of an Ub signal promotes Smo localization in the late
endosome. Thus, ubiquitination of Smo most likely promotes Smo
endocytosis in a similar manner as that seen for other plasma
membrane proteins where ubiquitination regulates endocytosis
[24]. We have also discovered an additional molecular mechanism
of Smo activation by demonstrating that Hh activates Smo by
inhibiting its ubiquitination. We sought to understand the
mechanism by which Hh reduces Smo ubiquitination and found
that the inactivation of USP8 by RNAi or by the expression of a
dominant negative USP8 abolished the effects of Hh on Smo
ubiquitination. These data suggest that USP8 is required for the
Hh effects on Smo ubiquitination. The findings that Hh promotes
the interaction between Smo and its DUB, and that phosphor-
ylation of Smo further promotes this interaction, helped us to
better understand the underlying molecular mechanisms. In
addition, Hh may regulate the assembly of the trafficking
complexes, which could include USP8. One piece of evidence
came from our finding that the deletion of the MIT and the
RHOD domains in USP8C.S abolished the dominant negative
effect, indicating that the N-terminal portion of USP8 (aa1–287)
was necessary for the mutant to act as dominant negative protein,
possibly through the interaction with the component(s) of the
endosomal sorting complex required for transport (ESCRT). In
support of this model, mutating hrs has been shown to cause an
accumulation of Smo in Drosophila ovarian follicle cells [43] or in
wing imaginal discs (Li et al., this issue; our unpublished
observation), and therefore Hrs may recognize ubiquitinated
Smo and target Smo to the lysosome for degradation. It is also
possible that Hh may regulate Smo ubiquitin ligase(s) that are as
yet undefined.
Here, we have shown that Smo accumulates on the cell surface
when Shi is inactivated, suggesting that Smo functions through
Shi-mediated endocytosis. Although our observations support the
notion that USP8 deubiquitinates Smo and prevents localization
to early endosomes, we are not suggesting that USP8 play an
exclusive role in the inhibition of Smo endocytosis. It is also
possible that USP8 promotes Smo recycling to the cell surface.
Future studies will focus on determining the route of Smo
movement to the cell surface.
The Role of USP8 in Regulating Smo
USP family members have been shown to be involved in the
regulation of different cellular pathways [44]. USP8 was first
described as a growth-regulated ubiquitin isopeptidase that plays a
possible role in the control of mammalian cell proliferation [45].
There is increasing evidence that USP8 has a role in endosomal
sorting [28,29,46]. The identification and characterization of
USP8 in this study as a DUB involved in the reduction of Smo
ubiquitination has provided the opportunity to further understand
the functions of USP8 in regulating membrane protein trafficking.
We have characterized the role of USP8 in the regulation of Smo
cell surface expression that is critical for Smo activation. We have
also provided evidence that USP8 is required for Hh-induced Smo
accumulation. However, although the overexpression of USP8
increased the levels of Smo in vivo, it failed to induce Hh target
gene expression in A-compartment cells located away from the A/
P boundary. Our explanation is that the increase in Smo levels
that was induced by USP8 was still inhibited by Ptc, since we
found that USP8 induced more severe overgrowth phenotypes in
the ptc mutant background (Figure 6R–T). It is also possible that
USP8 might have additional function(s) in the Hh pathway by
targeting other component(s).
Materials and Methods
Constructs, Mutants, and Transgenes
The Myc-Smo, Myc-SmoCT, and Myc-SmoDCT constructs
have been previously described [35]. To construct Flag-tagged
DUBs, we obtained full-length cDNA from either DGRC or by
RT-PCR from fly embryonic RNA, amplified the cDNA
fragments, and sub-cloned them into the 2xFlag-UAST vector.
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Flag-USP8C.S was generated by site-directed mutagenesis and
sub-cloned into the 2xFlag-UAST. The HA-tagged USP8,
USP8C.S, USP8NT1 and USP8NT1C.S (aa 128–896),
USP8NT2 and USP8NT2C.S (aa 287–896), USP8NT3 and
USP8NT3C.S (aa 523–896), USP8CT1 (aa 1–534), and
USP8CT3 (aa 1–286) were constructed by inserting the coding
sequences into the 2xHA-UAST vector. Myc-SmoUb and Myc-
SmoCFP were constructed by sub-cloning the Ub and CFP
sequences in frame with the C-terminus of Myc-Smo, respectively.
To generate GFP-SmoUb, the GFP sequence was used to replace
Myc in Myc-SmoUb. Smo variants with substitutions at Lysine
residues were generated by site-directed mutagenesis in the
background of Myc-Smo. To construct Myc-hSmo, 6xMyc tag
was introduced into the XhoI site after the signal peptide of human
Smo, and then subcloned into pCDNA. RFP-Rab5 and RFP-
Rab7 were constructed by fusing the RFP sequence in frame to the
N-terminus of Rab5 or Rab7. The HA-tagged Ub and Ub
mutants were constructed by swapping the cDNA fragments into
the 2xHA-UAST vector. UbK0 bears K to R mutations at all of
the lysine residues in Ub. The UbK48 and UbK63 constructs have
mutations at all of the lysine residues, with the exception of K48
and K63, respectively. The UbK11R, UbK29R, UbK48R, and
UbK63R have single K to R mutations as indicated. The
generation of transgenes at the 75B1 attP locus (resulting VK5
lines) has been previously described [30]. The VK5-Flag-USP8,
USP8C.S, HA-USP8NT3, USP8NT3C.S, Myc-SmoUb, and
Myc-SmoCFP transgenes were generated using the same ap-
proach. The RNAi lines that targeted each DUB in the Drosophila
genome were obtained from the Vienna Drosophila RNAi Center
(VDRC) (Table S1) [47]. USP8 RNAi lines (v8931 and v107623)
were consistent in terms of the adult wing phenotypes and the
effects on Smo accumulation in wing discs. Shi RNAi lines (v3798
and v3799) obtained from the VDRC gave rise to similar
phenotypes when driven by MS1096 Gal4. UAS-Shi-DN, UAS-
Rab5, ptcH84, and ptcIN108 strains have been previously described
(Flybase) [36,48,49]. The usp8 mutant (usp8KO) and pka mutant
(DC0E95) have been previously described [12,28]. To generate
mutant clones, FRT/FLP-mediated mitotic recombination was
used for the following genotypes: usp8 clone: yw hsp-flp/+ or Y;
FRT82 usp8D/FRT82 hsp-GFP, or yw hsp-flp/+ or Y; FRT82 usp8-
KO/FRT82 ubi-lacZ. DC0 clone: yw hsp-flp/+ or Y; DC0E95 stc
FRT40/hsp-GFP FRT40. The MS1096 Gal4, act.CD2.Gal4,
UAS-GFP-Smo, dpp-lacZ, and ptc-lacZ fly lines have been previously
described [35].
Antibody Production
The USP8 antibody was generated by Genemed Synthesis Inc.
in rabbits immunized with peptides corresponding to aa1–16 and
452–470 of USP8. The anti-SmoP antibody was generated by the
same company to specifically detect Smo phosphorylation at the
2nd cluster (anti-SmoP). Antigen peptide CRHVSVESRRN(pS)
VD(pS)QV(pS)VK was injected into the rabbits, the serum was
affinity-purified with the antigen, and the flow-through was kept as
a control antibody against non-phosphorylated peptide (Fan et al.,
unpublished).
Cell Culture, Transfection, Immunoprecipitation, Western
Blot, and GST Fusion Protein Pull-Down
S2 cells were cultured as previously described [31]. Transfec-
tions were carried out using Effectene transfection reagent
(Qiagen). The immunoprecipitation and immunoblot analysis
were performed using a standard protocol. Faf, USP8, CG12082,
USP7, CG7288, CG9448, NOT, CG4165, Ec, CYLD, and
USP36 dsRNA were synthesized against nucleotides 2310–2910,
821–1670, 151–750, 181–750, 151–750, 175–670, 481–1070,
151–730, 2942–3542, 21–596, and 932–1532 of each correspond-
ing gene, respectively. GFP dsRNA synthesis and the method for
treating S2 cells with dsRNA have been previously described [31].
Hh treatment was carried out by using 60% Hh-conditioned
medium unless otherwise specified. NH4Cl (Sigma-Aldrich) was
used as a lysosomal inhibitor at a final concentration of 10–15 mM
for 24 h before harvesting the cells. H-89 and CK1-7 were used as
the PKA and CK1 inhibitors at a concentration of 10 mM and
100 mM, respectively, as previously described [12]. NIH3T3 cells
were cultured in DMEM medium containing 10% bovine calf
serum in a humidified incubator with 5% CO2. After 24 h post-
transfection, the medium was changed to DMEM with 0.5%
bovine calf serum with or without recombinant mouse Shh (R&D
Systems). HEK293T cells were cultured in DMEM containing
10% fetal bovine serum (FBS). Transfection of NIH3T3 and
HEK293T cells were carried out using FuGENE6 (Roche). GST-
Smo was constructed by fusing Smo aa625–753 to the GST
backbone. The GST fusion protein pull-down has been previously
described [30].
In Vivo Ubiquitination Assay
To examine the levels of ubiquitinated Smo, S2 cells were
transfected with Myc-Smo and then lysed with denaturing buffer
(1% SDS, 50 mM Tris, pH 7.5, 0.5 mM EDTA, and 1 mM
DTT) and incubated at 100uC for 5 min. The lysates were then
diluted 10-fold with regular lysis buffer containing 1.5 mM MgCl2
and subjected to immunoprecipitation with an anti-Myc antibody.
The protein was then resolved on an 8% SDS-PAGE, and an
immunoblot was performed using an anti-ubiquitin antibody (to
detect the endogenous Ub) or an anti-HA antibody (to detect the
HA-Ub or HA-Ub mutants). The ubiquitination of Myc-hSmo
from NIH3T3 cells was examined by the same immunoprecipi-
tation assay as used for Myc-Smo. The antibodies used for
Western blot included the following: mouse anti-Myc (9E10, Santa
Cruz, 1:5,000), anti-Flag (M2, Sigma, 1:10,000), anti-b-tubulin
(DSHB, 1:2,000), anti-ubiquitin (P4D1, Santa Cruz, 1:500), anti-
GFP (Millipore, 1:1,000), and anti-GST (Santa Cruz, 1:10,000);
rabbit anti-USP8 (this study, 1:200), and anti-SmoP (Fan et al.,
unpublished, 1:50).
Cell Surface Staining, Antibody Uptake, and Protein
Localization Assays
The cell-based assay to detect Smo cell surface accumulation
was carried out by immunostaining with an anti-SmoN antibody
(DSHB, 1:100) before cell permeabilization [31]. For the antibody
uptake assay, transfected S2 cells were incubated with the anti-
SmoN antibody (DSHB, 1:100, concentrated) in S2 cell medium
for 2 h at 25uC, fixed, and permeabilized. The fixed cells were
then stained with an anti-Rab5 antibody (Abcam, 1:300), washed,
and then stained with a secondary antibody. Z-scan sections of
regular cells (12–14 mm in diameter) were taken at 0.7 mm by
confocal imaging (Olympus Fluoview, Ver.1.7c) to monitor the
Rab5-positive endosomes and to quantify the Smo that was
endocytosed after intensity projection over the z-axis. CFP-Smo
signals were used to normalize the overall levels of transfected
Smo. For quantification, an autoradiography densitometric
analysis was performed using Metamorph software. Protein co-
localization assays were carried out by co-transfecting S2 cells with
Smo or USP8 constructs in combination with RFP-Rab7 or RFP-
Rab5, followed by immunostaining and confocal analysis. Where
appropriate, the experimental groups were compared using the
Student’s two-tailed t test, with significance defined as p,0.05.
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FISH, Embryo Staining, and Wing Disc Immunostaining
For fluorescence in situ hybridization (FISH), yw wing discs
from third instar larvae were collected and USP8 RNA probes
were prepared according to the instruction of the DIG RNA
labeling kits (Roach). After fixation, hybridization, and post-
hybridization washes, wing discs were subjected to secondary
antibody incubation and then washed with PBT buffer. For
embryo immunostaining, stage 11 embryos from specific geno-
types were dechorionated, fixed in solution containing 80%
Heptane, and immunostained with the indicated antibodies.
Act5C-Gal4 (Flybase) was used to drive the expression of UAS-
USP8RNAi or UAS-USP8C.S in embryos. A standard protocol
was used for the immunostaining of wing discs from late third
instar larvae. Antibodies used in this study were as follows: mouse
anti-Myc (9E10, Santa Cruz, 1:50), anti-Flag (M2, Sigma, 1:150),
anti-ubiquitin (FK2, BIOMOL, 1:50), anti-ubiquitin (P4D1, Santa
Cruz, 1:50), anti-SmoN (DSHB, 1:10), anti-Ptc (DSHB, 1:10), and
anti-En (DSHB, 1:20); rabbit anti-Flag (ABR, 1:150), anti-HA (Y-
11, Santa Cruz, 1:50), anti-b-Gal (Cappel, 1:1,500), and anti-GFP
(Clontech, 1:500); and rat anti-Ci, (2A, DSHB, 1:10).
Supporting Information
Figure S1 Mutating PKA in wing disc accumulates ubiquiti-
nated protein. (A–A0) A wing disc carrying DC0 clones was stained
with anti-Smo (red) and anti-GFP (green) antibodies. DC0 clones
lack GFP expression. The arrow in (A) shows the reduced Smo
accumulation in P-compartment cells. (B–C0) Wing discs carrying
DC0 clones were stained with anti-Ub FK2 or P4D1 antibody.
The anti-Ub FK2 antibody labeled the ubiquitinated proteins and
the anti-Ub P4D1 labeled the total levels of Ub in wing discs. Ub-
FK2 staining was elevated in cells mutating DC0 (arrow in B).
(TIF)
Figure S2 USP8 promotes Smo signaling activity (related to
Figure 7). (A–B9) Wing discs expressing GFP-Smo alone or in
combination with Flag-USP8 expressed by act.CD2.Gal4 were
stained for ptc-lacZ. Clones are marked by GFP expression. The
arrowheads in (A) and (B) indicate ectopic ptc-lacZ expression in
A-compartment cells located near the A/P boundary. The arrow
in (B) indicates the ectopic ptc-lacZ expression in cells located
away from the A/P boundary. (C–D9) Wing discs expressing
SmoSD123 alone or in combination with USP8RNAi expressed by
act.CD2.Gal4 were stained for ptc-lacZ and En. The arrows in
(C) and (C9) indicate the ectopic activation of Ptc and En by
SmoSD123. The arrows in (D) and (D9) indicate the reduction
of ptc-lacZ and En expression by USP8RNAi. (E–E90) A wing
disc expressing GFP-Smo together with HA-USP8NT3 by
act.CD2.Gal4 was stained for HA and Ptc-lacZ. The clones
are marked by GFP expression. The arrow indicates the ectopic
Ptc-lacZ expression that was induced by the co-expression of GFP-
Smo with USP8NT3.
(TIF)
Figure S3 The interaction between Smo and USP8 (related to
Figure 8). (A) S2 cells were co-transfected with Myc-Smo and the
indicated USP8 constructs, followed by immunoprecipitation with
the anti-Myc antibody and Western blot with either the anti-HA
antibody to detect the bound USP8 (top panel) or with the anti-
Myc antibody to detect the expression of Myc-Smo (middle panel).
IgG served as the loading control. Cell extracts were also subjected
to a direct Western blot with the anti-HA antibody to examine the
expression of HA-tagged USP8 or the truncated forms (bottom
panel). USP8, USP8NT1, NT2, NT3, and NT4 were pulled down
by Myc-Smo but not USP8CT1 or USP8CT3. See Figure 4E for
the diagram of the USP8 constructs. (B) S2 cells were transfected
with the indicated constructs followed by immunoprecipitation
and Western blot with the indicated antibodies. The arrow in the
top panel indicates full-length USP8, and the arrowhead indicates
USP8NT3, which were pulled down by Myc-Smo or Myc-
SmoCT (lanes 1, 3, 4, and 6) but not by Myc-SmoDC (lanes 2 and
5). The middle panel indicates the expression and input of Smo
protein. The bottom panel indicates the expression of USP8 that
was detected by Western blot with the anti-HA antibody. (C) S2
cells were co-transfected with Myc-SmoCT and the USP8
variants, followed by immunoprecipitation with the anti-Myc
antibody and Western blot with either the anti-HA antibody to
detect SmoCT-bound USP8 (top panel) or with the anti-Myc
antibody to detect the expression of Myc-Smo (middle panel). IgG
served as the loading control. Cell extracts were subjected to
Western blot with the anti-HA antibody to examine the expression
of HA-tagged USP8 or the truncated forms (bottom panel). USP8,
USP8NT1, NT2, NT3, and NT4 were pulled down by Myc-
SmoCT, but USP8CT1 and USP8CT3 were not. This result was
similar to the interaction pattern of full-length Smo.
(TIF)
Table S1 In vivo RNAi-mediated reduction of DUBs in the
Drosophila genome was performed by using the VDRC RNAi
library. The asterisks indicate that the RNAi-mediated reduction
of these DUBs via MS1096 Gal4 induced adult wing phenotypes.
(XLS)
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